Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Unknown 3 Recruiting 3 Withdrawn 2 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 10 Carcinoma, Non-Small-Cell Lung 10 Breast Neoplasms 9 Lung Neoplasms 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Leukemia, Myeloid, Acute 4 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Melanoma 3 Leukemia 3 Glioblastoma 3 Cholangiocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Gliosarcoma 2 Glioma 2 Congenital Abnormalities 2 Colonic Neoplasms 2 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stomatitis 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleural Effusion, Malignant 1 Pain 1

Interventions

Rituximab 66 Cyclophosphamide 52 fludarabine phosphate 26 fludarabine 22 Filgrastim 21 Vincristine 19 Methotrexate 19 Melphalan 19 Doxorubicin 18 Radiotherapy 17 Etoposide 17 Prednisone 16 Tacrolimus 15 Whole-Body Irradiation 14 Mycophenolic Acid 14 Cytarabine 14 Peripheral Blood Stem Cell Transplantation 13 Gemcitabine 13 Cyclosporine 13 Antilymphocyte Serum 13 Lenalidomide 12 Busulfan 11 Bortezomib 11 Granulocyte Colony-Stimulating Factor 9 Alemtuzumab 9 sargramostim 8 Dexamethasone 8 Cord Blood Stem Cell Transplantation 8 pembrolizumab 7 ibritumomab tiuxetan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma × Drug Therapy × Clear all

NCT01016795 2015-06-25

SCF980266

Aalborg University Hospital

Phase 2 Terminated

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡